AMAG Pharma (AMAG) Tops Q4 EPS by 13c
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Net loss before income taxes: 21.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net loss before income taxes: 21.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q4 EPS of $1.34, $0.13 better than the analyst estimate of $1.21. Revenue for the quarter came in at $108.7 million versus the consensus estimate of $120.13 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
- JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
